Funder
Chinese Center for Disease Control and Prevention
National Natural Science Foundation of China
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine
Reference38 articles.
1. Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates;Walsh;N Engl J Med,2020
2. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial;Han;Lancet Infect Dis,2021
3. Effectiveness of an inactivated SARS-CoV-2 vaccine in Chile;Jara;N Engl J Med,2021
4. Serum neutralising activity against SARS-CoV-2 variants elicited by CoronaVac;Chen;Lancet Infect Dis,2021
5. Dynamic SARS-CoV-2-specific B-cell and T-cell responses following immunization with an inactivated COVID-19 vaccine;Chen;Clin Microbiol Infect,2022